Humana Inc Stock News

Humana, Inc. (NYSE:HUM ) Q1 2024 Earnings Conference Call April 24, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR Bruce Broussard - CEO & Director James Rechtin - President & COO Susan Dia

Humana (NYSE:HUM) shares fell after it pulled its 2025 profit guidance, reigniting investor concerns about the impact of rising medical costs on the insurer's bottom line. Humana (NYSE:HUM) in Januar

Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street es

Humana (HUM) came out with quarterly earnings of $7.23 per share, beating the Zacks Consensus Estimate of $6.02 per share. This compares to earnings of $9.38 per share a year ago.

The health insurer Humana Wednesday reported quarterly net income of more than $741 million and boosted its forecast for Medicare Advantage membership growth.

Humana beat first-quarter profit expectations on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults.

Shares of Humana Inc. HUM, +0.82% charged 6.7% higher in premarket trading Wednesday, after the health insurer reported first-quarter profit and revenue that beat expectations by wide margins and boos

Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is l

Humana's (HUM) first-quarter results are likely to reflect rising premiums and investment income.

Evaluate the expected performance of Humana (HUM) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for

Humana (HUM) closed the most recent trading day at $324.83, moving +0.42% from the previous trading session.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2024 (1Q24), as well as prepared management remarks (in PDF format), on Wednesday, Ap

Investors with an interest in Medical - HMOs stocks have likely encountered both Cigna (CI) and Humana (HUM). But which of these two stocks is more attractive to value investors?